您的购物车当前为空
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.

SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 26,600 | 3-6月 | |
| 50 mg | ¥ 33,800 | 3-6月 | |
| 100 mg | ¥ 42,500 | 3-6月 |
SGL5213 相关产品
| 产品描述 | SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. |
| 靶点活性 | SGLT1/ SGLT2 (human):29nM/20 nM |
| 分子量 | 669.85 |
| 分子式 | C37H55N3O8 |
| CAS No. | 1240305-17-2 |
| 密度 | 1.182 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容